Sibylle Madlener

3.5k total citations · 1 hit paper
51 papers, 2.1k citations indexed

About

Sibylle Madlener is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sibylle Madlener has authored 51 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Sibylle Madlener's work include Glioma Diagnosis and Treatment (7 papers), MicroRNA in disease regulation (6 papers) and Sirtuins and Resveratrol in Medicine (6 papers). Sibylle Madlener is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), MicroRNA in disease regulation (6 papers) and Sirtuins and Resveratrol in Medicine (6 papers). Sibylle Madlener collaborates with scholars based in Austria, Germany and United States. Sibylle Madlener's co-authors include Thomas Ströbel, Okay Saydam, Erdoğan Pekcan Erkan, Can Dincer, Julia Baaske, Richard C. Bruch, Wilfried Weber, G. Urban, Arda Mizrak and Gokhan Baris Ozdener and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Oncogene.

In The Last Decade

Sibylle Madlener

47 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR/Cas13a‐Powered Electrochemical Microfluidic Biosensor for Nucleic Acid Amplification‐Free miRNA Diagnostics

2019 368 citations Richard C. Bruch, Julia Baaske et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sibylle Madlener Austria	22	1.6k	619	336	140	118	51	2.1k
Chern Ein Oon Malaysia	23	1.6k 1.0×	682 1.1×	193 0.6×	533 3.8×	225 1.9×	71	2.8k
Marco Fiorillo Italy	26	1.2k 0.7×	698 1.1×	244 0.7×	426 3.0×	88 0.7×	56	2.0k
Ernesto Yagüe United Kingdom	30	1.6k 1.0×	632 1.0×	216 0.6×	830 5.9×	110 0.9×	60	2.5k
Ling‐Wen Ding Singapore	29	1.6k 1.0×	541 0.9×	134 0.4×	506 3.6×	260 2.2×	65	2.4k
Farid Hashemi Iran	27	1.5k 0.9×	870 1.4×	278 0.8×	356 2.5×	114 1.0×	40	2.4k
Cristina P. R. Xavier Portugal	20	1.2k 0.7×	509 0.8×	246 0.7×	443 3.2×	159 1.3×	46	1.9k
Narges Baluch Canada	11	1.1k 0.6×	236 0.4×	333 1.0×	475 3.4×	157 1.3×	17	2.2k
Mohammad Gholami Iran	19	881 0.5×	539 0.9×	156 0.5×	231 1.6×	74 0.6×	47	1.5k
Tina S. Homayouni Canada	4	999 0.6×	223 0.4×	310 0.9×	430 3.1×	146 1.2×	4	1.9k

Countries citing papers authored by Sibylle Madlener

Since Specialization

Citations

This map shows the geographic impact of Sibylle Madlener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sibylle Madlener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sibylle Madlener more than expected).

Fields of papers citing papers by Sibylle Madlener

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sibylle Madlener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sibylle Madlener. The network helps show where Sibylle Madlener may publish in the future.

Co-authorship network of co-authors of Sibylle Madlener

This figure shows the co-authorship network connecting the top 25 collaborators of Sibylle Madlener. A scholar is included among the top collaborators of Sibylle Madlener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sibylle Madlener. Sibylle Madlener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madlener, Sibylle, Christine Haberler, Walter Berger, et al.. (2024). EPEN-12. EZHIP IMPACTS CELLULAR DIFFERENTIATION IN POSTERIOR FOSSA GROUP A EPENDYMOMA. Neuro-Oncology. 26(Supplement_4). 0–0.

Senfter, Daniel, Julia Furtner, Christine Haberler, et al.. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 15(9). 2525–2525. 8 indexed citations

Madlener, Sibylle, Julia Furtner, Daniel Senfter, et al.. (2023). Clinical applicability of miR517a detection in liquid biopsies of ETMR patients. Acta Neuropathologica. 145(6). 843–846. 3 indexed citations

Pinter, Matthias, Daniel Senfter, Sibylle Madlener, et al.. (2021). Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives. Materials. 14(9). 2138–2138. 7 indexed citations

Laggner, Maria, Alfred Gugerell, Dragan Copic, et al.. (2021). Comparing the efficacy of γ- and electron-irradiation of PBMCs to promote secretion of paracrine, regenerative factors. Molecular Therapy — Methods & Clinical Development. 21. 14–27. 3 indexed citations

Bruch, Richard C., Midori Johnston, André Kling, et al.. (2021). CRISPR-powered electrochemical microfluidic multiplexed biosensor for target amplification-free miRNA diagnostics. Biosensors and Bioelectronics. 177. 112887–112887. 162 indexed citations

Laggner, Maria, Alfred Gugerell, Christiane Bachmann, et al.. (2020). Reproducibility of GMP-compliant production of therapeutic stressed peripheral blood mononuclear cell-derived secretomes, a novel class of biological medicinal products. Stem Cell Research & Therapy. 11(1). 9–9. 38 indexed citations

Pinter, Matthias, Daniel Senfter, Sibylle Madlener, et al.. (2020). Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton. Molecules. 25(10). 2355–2355. 9 indexed citations

Traxler, Denise, Elisabeth Simader, Lucian Beer, et al.. (2018). Different pro-angiogenic potential of γ-irradiated PBMC-derived secretome and its subfractions. Scientific Reports. 8(1). 18016–18016. 35 indexed citations

10.

Ströbel, Thomas, Sibylle Madlener, Sarah Vose, et al.. (2017). Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma. Scientific Reports. 7(1). 9674–9674. 31 indexed citations

11.

Senfter, Daniel, Sibylle Madlener, Georg Krupitza, & Robert M. Mader. (2016). The microRNA-200 family: still much to discover. BioMolecular Concepts. 7(5-6). 311–319. 72 indexed citations

12.

Erkan, Erdoğan Pekcan, Thomas Ströbel, Bakhos A. Tannous, et al.. (2013). Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo. Oncogene. 33(39). 4778–4785. 39 indexed citations

13.

Saiko, Philipp, Sibylle Madlener, Georg Krupitza, et al.. (2011). Combination Effects of Digalloylresveratrol With Arabinofuranosylcytosine and Difluorodeoxycytidine in Human Leukemia and Pancreatic Cancer Cells. Nucleosides Nucleotides & Nucleic Acids. 30(12). 1190–1196. 1 indexed citations

14.

Giessrigl, Benedikt, Caroline Vonach, Sibylle Madlener, et al.. (2009). Berberine and a Berberis lycium extract inactivate Cdc25A and induce α-tubulin acetylation that correlate with HL-60 cell cycle inhibition and apoptosis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 683(1-2). 123–130. 43 indexed citations

15.

Özmen, Ali, Sibylle Madlener, Sabine Bauer, et al.. (2009). In vitro anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey. Phytomedicine. 17(1). 55–62. 38 indexed citations

16.

Bernhaus, Astrid, Mária Ozsvár-Kozma, Philipp Saiko, et al.. (2008). Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. Investigational New Drugs. 27(5). 393–401. 23 indexed citations

17.

Madlener, Sibylle, Susanne Maier, Philipp Saiko, et al.. (2008). Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Oncology Reports. 19(3). 801–10. 21 indexed citations

18.

Maier, Susanne, S Strasser, Philipp Saiko, et al.. (2006). Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC. APOPTOSIS. 11(3). 427–440. 15 indexed citations

19.

Strasser, Stephen, Susanne Maier, C. Leisser, et al.. (2006). 5-FdUrd–araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2. Differentiation. 74(9-10). 488–498. 21 indexed citations

20.

Bagó-Horváth, Zsuzsanna, Marek Murias, Philipp Saiko, et al.. (2006). Cytotoxic and biochemical effects of 3,3′,4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Experimental Hematology. 34(10). 1377–1384. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact